EUVIMEDEUVIMED entdecken
Crossref

Stem cell membrane-coated rough mesoporous silica nanoparticles for enhanced osteogenic differentiation and bone repair via dexamethasone delivery

Peng Chen, Jiawei Lu, Yi Liu, Hongwei Wang, Yaguang Han, Xiaoji Luo iD

Biomedical Materials · 2025

DOI: 10.1088/1748-605x/ae0bda ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Materials, 2025. Verfasst von Peng Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China. Hauptthemen laut MEDLINE: Dexamethasone, Osteogenesis, Silicon Dioxide, Mesenchymal Stem Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesoporous silica nanoparticles (MSNs) have been demonstrated to promote osteoblast differentiation; however, the unclear impact of their surface roughness on osteogenesis, coupled with inadequate targeting capability and suboptimal therapeutic outcomes, presents major challenges. Herein, we developed a biomimetic nanoplatform, CM@DEX-R-MSN, by coating dexamethasone (DEX) loaded-rough MSN (R-MSN) with mesenchymal stem cell (MSC) membranes (CM) to enhance osteogenic differentiation of MSCs for improved bone regeneration. The CM@DEX-R-MSN showed retained rough surfaces with a hydrodynamic diameter of 164.35 ± 5.81 nm, a Zeta potential of −11.98 ± 1.37 mV with good MSC membrane integrity, negligible cytotoxicity both in vitro and in vivo . CM@DEX-R-MSN exhibited significantly enhanced MSC internalization compared to uncoated MSN. They markedly upregulated alkaline phosphatase activity, osteogenic markers, and mineralization nodule formation in vitro . In bone defect model established in rabbits, CM@DEX-R-MSN restored bone volume and prolonged retention at the defect site. More importantly, we experimentally observed that both R-MSN and CM-coated nanoparticles exhibited superior osteogenic differentiation effects compared to conventional MSNs and non-coated counterparts, respectively—with CM@DEX-R-MSN demonstrating the most potent efficacy. Our results demonstrated that CM@DEX-R-MSN synergistically integrates MSC membrane-mediated homotypic targeting, nanotopography of R-MSN, and DEX-driven osteogenic differentiation, offering a promising targeted therapeutic strategy for bone regeneration. Their enhanced biocompatibility, osteogenic efficacy, and sustained retention underscore its translational potential for orthopedic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneOsteogenesisSilicon DioxideMesenchymal Stem CellsBone RegenerationNanoparticlesAnimalsCell DifferentiationRabbitsPorosityCell MembraneHumansDrug Delivery SystemsOsteoblasts

Stichwörter der Autor:innen

bone regenerationdexamethasonemesenchymal stem cell membraneosteogenic differentiationrough mesoporous silica nanoparticlestargeted delivery

Substanzen

DexamethasoneSilicon Dioxide

Autor:innen und Institutionen

  • Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
  • Department of Orthopedics, The People's Hospital of Guizhou Province, Guiyang, Guizhou, People's Republic of China.
  • Department of Pathology, The Fourth Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Department of Orthopedics, Tongren Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Department of Orthopedics, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.

ORCID-Profile: Xiaoji Luo

Zitieren

APA

Chen, P., Lu, J., Liu, Y., Wang, H., Han, Y., & Luo, X. (2025). Stem cell membrane-coated rough mesoporous silica nanoparticles for enhanced osteogenic differentiation and bone repair via dexamethasone delivery. Biomedical Materials. https://doi.org/10.1088/1748-605x/ae0bda

Vancouver

Chen P, Lu J, Liu Y, Wang H, Han Y, Luo X. Stem cell membrane-coated rough mesoporous silica nanoparticles for enhanced osteogenic differentiation and bone repair via dexamethasone delivery. Biomedical Materials. 2025. doi:10.1088/1748-605x/ae0bda

BibTeX
@article{Chen2025,
  author = {Chen, Peng and Lu, Jiawei and Liu, Yi and Wang, Hongwei and Han, Yaguang and Luo, Xiaoji},
  title = {Stem cell membrane-coated rough mesoporous silica nanoparticles for enhanced osteogenic differentiation and bone repair via dexamethasone delivery},
  journal = {Biomedical Materials},
  year = {2025},
  doi = {10.1088/1748-605x/ae0bda}
}
Kostenlos starten →